blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1169066

EP1169066 - A NOVEL METHOD OF DIAGNOSING, MONITORING, STAGING, IMAGING AND TREATING GYNECOLOGIC CANCERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.02.2006
Database last updated on 03.10.2024
Most recent event   Tooltip18.12.2009Change - representativepublished on 20.01.2010  [2010/03]
Applicant(s)For all designated states
Diadexus, Inc.
343 Oyster Point Boulevard
South San Francisco, CA 94080 / US
[2002/33]
Former [2002/27]For all designated states
diaDexus, Inc.
3303 Octavius Drive
Santa Clara, CA 95054 / US
Former [2002/02]For all designated states
Diadexus LLC
3303 Octavius Drive
Santa Clara, CA 95054 / US
Inventor(s)01 / MACINA, Roberto, A.
4118 Crescendo Avenue
San Jose, CA 95136 / US
 [2002/02]
Representative(s)Suèr, Steven Johannes, et al
Ablett & Stebbing
7-8 Market Place
London W1W 8AG / GB
[N/P]
Former [2010/03]Suèr, Steven Johannes, et al
Ablett & Stebbing, Caparo House, 101-103 Baker Street
London W1U 6FQ / GB
Former [2002/02]Suèr, Steven Johannes, et al
Ablett & Stebbing, Caparo House, 101-103 Baker Street
London W1M 1FD / GB
Application number, filing date99951679.230.09.1999
[2002/02]
WO1999US22753
Priority number, dateUS19980102743P02.10.1998         Original published format: US 102743 P
[2002/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0020044
Date:13.04.2000
Language:EN
[2000/15]
Type: A1 Application with search report 
No.:EP1169066
Date:09.01.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 13.04.2000 takes the place of the publication of the European patent application.
[2002/02]
Search report(s)International search report - published on:US13.04.2000
(Supplementary) European search report - dispatched on:EP17.09.2002
ClassificationIPC:A61K51/00
[2002/02]
CPC:
G01N33/57449 (EP); A61K51/1045 (EP); C12Q1/6886 (EP);
G01N33/57411 (EP); G01N33/57415 (EP); G01N33/57488 (EP);
C12Q2600/112 (EP); C12Q2600/158 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/02]
TitleGerman:VERFAHREN ZUR DIAGNOSTIK, ÜBERWACHUNG, STADIUMFESTSTELLUNG, BILDGEBUNG UND BEHANDLUNG VON GYNAEKOLOGISCHEM KREBS[2005/19]
English:A NOVEL METHOD OF DIAGNOSING, MONITORING, STAGING, IMAGING AND TREATING GYNECOLOGIC CANCERS[2002/02]
French:NOUVEAU PROCEDE POUR DIAGNOSTIQUER, CONTROLER, ETABLIR LE BILAN D'EXTENSION, VISUALISER, ET TRAITER DES CANCERS GYNECOLOGIQUES[2002/02]
Former [2002/02]VERFAHREN ZUR DIAGNOSTIK, ÜBERWACHUNG, STADIUMFESTSTELLUNG, BILDGEBUNG UND BEHANDLUNG VON GYNAEKOLOGISCHER KREBS
Entry into regional phase02.05.2001National basic fee paid 
02.05.2001Search fee paid 
02.05.2001Designation fee(s) paid 
02.05.2001Examination fee paid 
Examination procedure01.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: US
02.05.2001Examination requested  [2002/02]
12.09.2003Despatch of a communication from the examining division (Time limit: M06)
22.03.2004Reply to a communication from the examining division
05.08.2004Despatch of a communication from the examining division (Time limit: M04)
13.12.2004Reply to a communication from the examining division
04.05.2005Communication of intention to grant the patent
15.09.2005Application deemed to be withdrawn, date of legal effect  [2006/12]
19.10.2005Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2006/12]
Fees paidRenewal fee
02.05.2001Renewal fee patent year 03
05.09.2002Renewal fee patent year 04
04.09.2003Renewal fee patent year 05
06.09.2004Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.200507   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]WO9919487  (INCYTE PHRAMACEUTICALS) [PX] 1-11 * figure 1 * * page 12, line 19 - page 13, line 1 * * page 32 - page 39 * * example 4 *;
 [Y]WO9807857  (ABBOTT LABORATORIES) [Y] 1-11 * SEQ ID No. 15; page 6, line 29 - page 7, line 15 * * page 11, line 18 - page 12, line 3 *;
 [Y]WO9821331  (INCYTE PHARMACEUTICALS, INC) [Y] 1-11 * SEQ ID No. 1; page 21, line 10 - page 22, line 13 *
 [PX]  - BECKER R M ET AL, "IDENTIFICATION OF MAMMAGLOBIN B, A NOVEL MEMBER OF THE UTEROGLOBIN GENE FAMILY", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (1998), vol. 54, no. 1, ISSN 0888-7543, pages 70 - 78, XP000892829 [PX] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1006/geno.1998.5539
 [Y]  - WATSON M A ET AL, "MAMMAGLOBIN, A MAMMARY-SPECIFIC MEMBER OF THE UTEROGLOBIN GENE FAMILY, IS OVEREXPRESSED IN HUMAN BREAST CANCER", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (19960215), vol. 56, ISSN 0008-5472, pages 860 - 865, XP002048615 [Y] 1-11 * abstract * * figure 1 *
International search[Y]WO9734997  ;
 [A]WO9638463  ;
 [Y]  - KOSHIYAMA ET AL., "Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathalogic features and sex steroid receptor status", INT. J. CANCER (PRED. ONCOL.),, (1997), vol. 74, pages 237 - 244, XP002924223

DOI:   http://dx.doi.org/10.1002/(SICI)1097-0215(19970620)74:3<237::AID-IJC1>3.0.CO;2-#
 [A]  - SCHMITT ET AL., "Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer", BRITISH J. OF CANCER,, (1997), vol. 76, pages 306 - 311, XP002924224
 [A]  - TARDIVEL-LACOMBE ET AL., "Immunohistochemical detection of the sex steroid-binding plasma protein in human mammary carcinoma cells", BIOCHEM. BIOPHYS. RES. COMMUN,, (19840130), vol. 118, no. 2, pages 488 - 494, XP002924225

DOI:   http://dx.doi.org/10.1016/0006-291X(84)91329-9
 [A]  - SASANO ET AL., "Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary", HUMAN PATHOLOGY,, (199606), vol. 27, no. 6, pages 595 - 598, XP002924226

DOI:   http://dx.doi.org/10.1016/S0046-8177(96)90168-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.